Multiple Noninvasive Examination Modality to Evaluate the Severity of Ocular Surface Disorders
NCT ID: NCT03594370
Last Updated: 2019-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2018-06-08
2019-05-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using AS-OCT to Assess the Role of Age and Region in the Morphology and Epithelial Thickness of Limbus
NCT02500134
Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Ocular Diseases
NCT00249392
Optical Coherence Tomography Angiography Criteria Of The Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia (Comparative Study).
NCT05562336
Identification and Measurement of Antioxidants and Cytokines in the Anterior Chamber of Various Ocular Disorders
NCT04101591
Explainable Ocular Fundus Diseases Report Generation System
NCT05622565
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Here the investigators proposed this clinical trial to collect cases of different etiologies of ocular surface diseases. With at least one of these four non-invasive examination modalities, the investigators aim to analyze and compare the detecting results. The investigators especially focus on the possibility of using ASOCT to predict the condition of limbal epithelial stem cells, aiming to use this patient-friendly tool to detect the patient's limbal conditions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
Limbal image by OCT in normal subjects.
No interventions assigned to this group
Advancing wave-like epitheliopathy
Limbal image by OCT in subjects with advancing wave-like epitheliopathy.
No interventions assigned to this group
Ocular rosacea or phlyctenulosis
Limbal image by OCT in subjects with ocular rosacea or phlyctenulosis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient or the legal representative is able to read and sign an informed consent form.
* Patient with one of the diagnosis listed below:
1. limbal insufficiency
2. phlyctenulosis
3. ocular rosacea
4. ocular graft-versus-host disease (GVHD)
5. dry eye syndrome (both aqueous deficiency or increased evaporative forms of dry eyes)
6. other ocular surface diseases (advancing wave-like epitheliopathy, long term use of anti-glaucoma eye drops)
Exclusion Criteria
* Patients younger than 5 years old.
5 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wei-Li Chen
Role: STUDY_DIRECTOR
NTUH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NTUH
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201803133RINC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.